BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 11049089)

  • 1. Synthesis and cellular effects of novel 1,3,5-triazine derivatives in DLD and Ht-29 human colon cancer cell lines.
    Wróbel A; Kolesińska B; Frączyk J; Kamiński ZJ; Tankiewicz-Kwedlo A; Hermanowicz J; Czarnomysy R; Maliszewski D; Drozdowska D
    Invest New Drugs; 2020 Aug; 38(4):990-1002. PubMed ID: 31520321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential of Nitrogen Mustard Based Hybrid Molecules.
    Chen Y; Jia Y; Song W; Zhang L
    Front Pharmacol; 2018; 9():1453. PubMed ID: 30618747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization and evaluation of 1,3,5-triazine aminobenzoic acid derivatives for their antimicrobial activity.
    Al-Zaydi KM; Khalil HH; El-Faham A; Khattab SN
    Chem Cent J; 2017 May; 11(1):39. PubMed ID: 29086830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Preliminary Biological Evaluation of 1,3,5-Triazine Amino Acid Derivatives to Study Their MAO Inhibitors.
    Khattab SN; Khalil HH; Bekhit AA; El-Rahman MM; El-Faham A; Albericio F
    Molecules; 2015 Sep; 20(9):15976-88. PubMed ID: 26364629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) on the liver metastasis of colon 26-L5 carcinoma cells.
    Sakukawa R; Murakami K; Ikeda T; Yamada Y; Saiki I
    Oncol Res; 1998; 10(6):287-93. PubMed ID: 9848099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.
    Kimura Y; Sumiyoshi M; Baba K
    Cancer Sci; 2008 Oct; 99(10):2083-96. PubMed ID: 19016770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
    Sava G; Zorzet S; Turrin C; Vita F; Soranzo M; Zabucchi G; Cocchietto M; Bergamo A; DiGiovine S; Pezzoni G; Sartor L; Garbisa S
    Clin Cancer Res; 2003 May; 9(5):1898-905. PubMed ID: 12738748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological properties of 4-methyl-2,7-diamino-5,10-diphenyl-4,9-diazapyrenium hydrogensulfate (ADAP).
    Marczi S; Glavas-Obrovac L; Belovari T; Stojković R; Ivanković S; Serić V; Piantanida I; Zinić M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):595-604. PubMed ID: 18034344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis.
    Yamakawa S; Asai T; Uchida T; Matsukawa M; Akizawa T; Oku N
    Cancer Lett; 2004 Jul; 210(1):47-55. PubMed ID: 15172120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimetastatic and antitumor effects of 2,4-diamino-6-(pyridine-4-yl)-1,3,5-triazine (4PyDAT) on the high lung metastatic colon 26 tumor in mice.
    Maeda M; Ligo M; Tsuda H; Fujita H; Yonemura Y; Nakagawa K; Endo Y; Sasaki T
    Anticancer Drug Des; 2000 Jun; 15(3):217-23. PubMed ID: 11049089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anticancer agents: in vitro and in vivo evaluation of the antitumor and antimetastatic actions of various compounds isolated from medicinal plants.
    Kimura Y
    In Vivo; 2005; 19(1):37-60. PubMed ID: 15796155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new antimetastatic agents: review of in vitro and in vivo screening methods.
    Li HF; Wang XW; Zhang RG; Yuan JH; Xie Y; Xie H
    Methods Find Exp Clin Pharmacol; 2000 Mar; 22(2):123-8. PubMed ID: 10849896
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.